Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.

Progress in neurobiology - 1 Nov 2013

Roberts J Scott, Uhlmann Wendy R

Abstract excerpt

As the genetics of neurodegenerative disease become better understood, opportunities for genetic susceptibility testing for at-risk individuals will increase. Such testing raises important ethical and practice issues related to test access, informed consent, risk estimation and communication, return of results, and policies to prevent genetic discrimination. The advent of direct-to-consumer genetic susceptibility...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to APOE gene
Share to Genetic Counseling
Share to Genetic Neurodegenerative Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Neurodegenerative Diseases

Share to Prion Diseases and Protein Misfolding

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 23583530
DOI: 10.1016/j.pneurobio.2013.02.005
PMCID: PMC3772971

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.PMID 23583530Read ↗

Ethical, Legal and Social Implications of Susceptibility Genetic Testing for Late-Onset Neurodegenerative DiseasesSemantic proximity Read ↗

Genetic testing for neurodegenerative diseases: Ethical and health communication challenges.Semantic proximity Read ↗

Genetic testing and Alzheimer disease: recommendations of the Stanford Program in Genomics, Ethics, and Society.Semantic proximity Read ↗

Diagnostic testing in neurogenetics. Principles, limitations, and ethical considerations.Semantic proximity Read ↗

The ethics of disclosing genetic diagnosis for Alzheimer's disease: do we need a new paradigm?Semantic proximity Read ↗

On not jumping the gun: ethical aspects of APOE gene testing for Alzheimer's disease.Semantic proximity Read ↗

The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease.Semantic proximity Read ↗

Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.Semantic proximity Read ↗

Genetic testing and Alzheimer disease: has the time come? Alzheimer Disease Working Group of the Stanford Program in Genomics, Ethics & Society.Semantic proximity Read ↗

I Had Genetic Testing for Alzheimer's Disease Without My Consent.Semantic proximity Read ↗

Ethical considerations in psychiatric genetics.Semantic proximity Read ↗

Predictive genetic testing for neurodegenerative conditions: how should conflicting interests within families be managed?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.